<?xml version="1.0" encoding="UTF-8"?>
<ref id="B112-pharmaceutics-13-00631">
 <label>112.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barreto da Silva</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Camargo</surname>
    <given-names>S.B.</given-names>
   </name>
   <name>
    <surname>Moraes</surname>
    <given-names>R.d.A.</given-names>
   </name>
   <name>
    <surname>Medeiros</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Jesus</surname>
    <given-names>A.d.M.</given-names>
   </name>
   <name>
    <surname>Evangelista</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Villarreal</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Quintans-Júnior</surname>
    <given-names>L.J.</given-names>
   </name>
   <name>
    <surname>Silva</surname>
    <given-names>D.F.</given-names>
   </name>
  </person-group>
  <article-title>Antihypertensive effect of carvacrol is improved after incorporation in β-cyclodextrin as a drug delivery system</article-title>
  <source>Clin. Exp. Pharmacol. Physiol.</source>
  <year>2020</year>
  <volume>47</volume>
  <fpage>1798</fpage>
  <lpage>1807</lpage>
  <pub-id pub-id-type="doi">10.1111/1440-1681.13364</pub-id>
  <pub-id pub-id-type="pmid">32568422</pub-id>
 </element-citation>
</ref>
